Pub Date : 2018-12-07DOI: 10.2174/1573400514666180903104001
A. Schmitt, Jody Clarke, C. Hickey
{"title":"Davanloo’s Techniques in the Case of A 17-year-old with Anorexia Nervosa and A Complex Unconscious: Part I","authors":"A. Schmitt, Jody Clarke, C. Hickey","doi":"10.2174/1573400514666180903104001","DOIUrl":"https://doi.org/10.2174/1573400514666180903104001","url":null,"abstract":"","PeriodicalId":51774,"journal":{"name":"Current Psychiatry Reviews","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1573400514666180903104001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44897703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-12-07DOI: 10.2174/1573400514666180816113159
P. Lysaker, Jay A. Hamm, Jenifer L. Vohs, M. Kukla, Michelle L Pattison, Bethany L. Leonhardt, John Lysaker
{"title":"Understanding the Course of Self-disorders and Alterations in Self- Experience in Schizophrenia: Implications from Research on Metacognition","authors":"P. Lysaker, Jay A. Hamm, Jenifer L. Vohs, M. Kukla, Michelle L Pattison, Bethany L. Leonhardt, John Lysaker","doi":"10.2174/1573400514666180816113159","DOIUrl":"https://doi.org/10.2174/1573400514666180816113159","url":null,"abstract":"","PeriodicalId":51774,"journal":{"name":"Current Psychiatry Reviews","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1573400514666180816113159","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43175213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-12-07DOI: 10.2174/1573400514666180816112109
Brittany Riggin and Caleb Lack
{"title":"Ethical Decision-Making Models Across Mental Health Treatment: A Review and Expansion","authors":"Brittany Riggin and Caleb Lack","doi":"10.2174/1573400514666180816112109","DOIUrl":"https://doi.org/10.2174/1573400514666180816112109","url":null,"abstract":"","PeriodicalId":51774,"journal":{"name":"Current Psychiatry Reviews","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1573400514666180816112109","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45844175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-10-18DOI: 10.2174/1573400514666180709144931
Zdravka Penkova, R. Stark, F. Leichsenring, Christiane Steinert
{"title":"The Effects of Waiting for Treatment: A Meta-analysis of Wait-list Control Groups in Randomized Controlled Trials for Panic Disorder","authors":"Zdravka Penkova, R. Stark, F. Leichsenring, Christiane Steinert","doi":"10.2174/1573400514666180709144931","DOIUrl":"https://doi.org/10.2174/1573400514666180709144931","url":null,"abstract":"","PeriodicalId":51774,"journal":{"name":"Current Psychiatry Reviews","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1573400514666180709144931","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43652084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-10-18DOI: 10.2174/1573396314666180710150541
G. Padovan, Rosa Preteroti, Beatrice Bortolato, M. Papaioannou, Giada Piva, G. Magnolfi
{"title":"High Sensitivity C-Reactive Protein as a Potential Biomarker of Neuroinflammation in Major Psychiatric Disorders","authors":"G. Padovan, Rosa Preteroti, Beatrice Bortolato, M. Papaioannou, Giada Piva, G. Magnolfi","doi":"10.2174/1573396314666180710150541","DOIUrl":"https://doi.org/10.2174/1573396314666180710150541","url":null,"abstract":"","PeriodicalId":51774,"journal":{"name":"Current Psychiatry Reviews","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48724984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-09-05DOI: 10.2174/1573400514666180612092055
Swapnil Gupta, S. Steingard, Elena Francesca Garcia, H. Fathy
Background: Standard guidelines for the management of chronic psychoses recommend the rapid initiation of treatment with antipsychotic medications (APs) and often, indefinite continuation. Ongoing treatment with APs is based primarily on evidence from AP discontinuation studies, which have several crucial flaws. Due to this equivocal evidence for continued treatment with APs and owing to their serious side effects, there is a critical need for considering controlled reduction and/or discontinuation of APs in persons with chronic psychoses. Discussion and Conclusion: Deprescribing has been defined as the systematic process of medication reduction and or discontinuation when current or potential harms outweigh current or potential benefits, taking into account a patient’s medical condition, functional status and their values and preferences. In this paper, we utilize the framework of deprescribing to answer the questions of why and how to reduce and/or discontinue treatment with APs. We first approach the complex issue of assessing the risk-benefit ratio of APs by examining the evidence for their continued benefit and their side effects. We emphasize deprescribing as a patient-centered process, using shared-decision making, psychosocial interventions and a flexible approach while prescribing. Finally, we present some of the limitations and challenges of using this approach in AP reduction and discontinuation.
{"title":"Deprescribing Antipsychotic Medications in Psychotic Disorders: How and Why?","authors":"Swapnil Gupta, S. Steingard, Elena Francesca Garcia, H. Fathy","doi":"10.2174/1573400514666180612092055","DOIUrl":"https://doi.org/10.2174/1573400514666180612092055","url":null,"abstract":"Background: Standard guidelines for the management of chronic psychoses recommend the rapid initiation of treatment with antipsychotic medications (APs) and often, indefinite continuation. Ongoing treatment with APs is based primarily on evidence from AP discontinuation studies, which have several crucial flaws. Due to this equivocal evidence for continued treatment with APs and owing to their serious side effects, there is a critical need for considering controlled reduction and/or discontinuation of APs in persons with chronic psychoses. Discussion and Conclusion: Deprescribing has been defined as the systematic process of medication reduction and or discontinuation when current or potential harms outweigh current or potential benefits, taking into account a patient’s medical condition, functional status and their values and preferences. In this paper, we utilize the framework of deprescribing to answer the questions of why and how to reduce and/or discontinue treatment with APs. We first approach the complex issue of assessing the risk-benefit ratio of APs by examining the evidence for their continued benefit and their side effects. We emphasize deprescribing as a patient-centered process, using shared-decision making, psychosocial interventions and a flexible approach while prescribing. Finally, we present some of the limitations and challenges of using this approach in AP reduction and discontinuation.","PeriodicalId":51774,"journal":{"name":"Current Psychiatry Reviews","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1573400514666180612092055","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44535679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：